Treatment and Management of Transthyretin-mediated (ATTR) Amyloidosis

The management of patients with transthyretin amyloidosis includes 2 main categories of disease-modifying therapies. This video discusses the role of TTR stabilizers and TTR silencers/knockdown agents along with heart failure and arrhythmia management for the management of patients with cardiac ATTR.

Please visit our post-module evaluation survey as well!
Link to survey: https://www.surveymonkey.com/r/8RL5D9K

Visit our website: https://hfsa.org/cardiobites
HFSA LinkedIn: https://www.linkedin.com/company/hfsa/
HFSA Twitter: https://twitter.com/HFSA
HFSA Learning Center: https://learningcenter.hfsa.org/
Join HFSA to enjoy member benefits: https://hfsa.org/membership/me....mbership-benefits-an